NCT06534697View on ClinicalTrials.gov

Fascia Iliaca Block for Postoperative Pain Control After Elective Hip Arthroplasty

NANot yet recruitingINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

July 22, 2024

Primary Completion Date

December 30, 2024

Study Completion Date

February 28, 2025

Conditions
Hip Osteoarthritis
Interventions
DRUG

Naropin, 0.2% Injectable Solution in Sodium chloride

Preoperative fascia iliaca block with 40 ml volume of naropin 0,25% in sodium chloride

DRUG

Naropin, 0.2% Injectable Solution in dextrose 5%

Preoperative fascia iliaca block with 40 ml volume of naropin 0,25% in dextrose 5%

DRUG

Dextrose 10 % in Water

Preoperative fascia iliaca block with 40 ml volume of dextrose 10%

All Listed Sponsors
lead

Foisor Orthopedics Clinical Hospital

OTHER

NCT06534697 - Fascia Iliaca Block for Postoperative Pain Control After Elective Hip Arthroplasty | Biotech Hunter | Biotech Hunter